Check out our most popular compounded medications! Get Started
Buprenorphine 0.5% Nasal Spray is a compounded medication, delivered in a liquid spray form for nasal administration. It is designed to provide targeted local or systemic effects through the nostrils. This medication is used to treat conditions such as opioid dependence, chronic pain, anxiety, depression, and insomnia. It is available at Bayview Pharmacy.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Buprenorphine 0.5% Nasal Spray is a compounded prescription medication specifically designed to alleviate moderate to severe pain. This long-acting opioid agonist functions by binding to opioid receptors in the brain, thereby blocking the effects of other opioids. The medication is delivered in a liquid formulation via a spray, intended for intranasal administration. This method of delivery allows for targeted local or systemic effects through the nostrils.
Available in a single-dose spray bottle, Buprenorphine 0.5% Nasal Spray is indicated for use in adults and adolescents aged 12 years and older who are experiencing moderate to severe pain. It is crucial to adhere to the prescribed dosage and duration of use, as exceeding these can lead to adverse effects. Potential side effects may include nausea, vomiting, constipation, dizziness, and drowsiness.
As a controlled substance, Buprenorphine 0.5% Nasal Spray should be prescribed and used with caution, particularly in patients with a history of substance abuse.
At Bayview Pharmacy, we prioritize the provision of high-quality care for our patients. If you have any queries or concerns about Buprenorphine 0.5% Nasal Spray or any other medication, please do not hesitate to contact us. We are here to assist you with your healthcare needs.
Buprenorphine 0.5% Nasal Spray is a compounded formulation specifically designed for the treatment of opioid dependence. This liquid formulation is delivered in a spray form for administration into the nasal cavity, providing targeted local or systemic effects through the nostrils. The active ingredient, buprenorphine, works by blocking the effects of opioids, thereby reducing cravings and withdrawal symptoms associated with opioid dependence.
It is crucial to understand that buprenorphine is not a substitute for other opioids and is not intended to treat pain. This medication is designed to aid in the management of opioid dependence and should be used under the supervision of a healthcare provider. Patients using Buprenorphine 0.5% Nasal Spray should be monitored closely for signs of abuse or misuse.
It is strongly advised not to use Buprenorphine 0.5% Nasal Spray in combination with other opioids, alcohol, or benzodiazepines due to the risk of serious side effects. Patients should also be advised to avoid activities requiring mental alertness or coordination until they have a clear understanding of how the medication affects them. This is to ensure their safety while on this medication.
If you have any questions or concerns regarding Buprenorphine 0.5% Nasal Spray, please do not hesitate to reach out to your healthcare provider. It is important to use this medication as directed and to communicate any changes in your condition to your healthcare provider promptly.
Buprenorphine 0.5% Nasal Spray is a compounded medication specifically designed to aid in the treatment of opioid dependence and opioid use disorder. The active ingredient, buprenorphine, is a partial opioid agonist that works by binding to opioid receptors in the brain, thereby producing a milder opioid effect compared to full opioid agonists such as heroin or oxycodone. This mechanism of action helps in blocking the effects of opioids, reducing cravings, and preventing relapse.
The nasal spray form of this medication is intended for maintenance therapy, which means it is used regularly to help prevent relapse. It is crucial to adhere to the instructions provided by your healthcare provider when using Buprenorphine 0.5% Nasal Spray. The typical recommended dose is one spray in each nostril once daily, preferably administered in the morning. It is advised not to increase the dose without consulting your healthcare provider. This medication is not intended to treat acute pain or to substitute other opioid medications.
While Buprenorphine 0.5% Nasal Spray is generally well tolerated, some users may experience common side effects such as headache, nausea, dizziness, and drowsiness. If you experience any of these side effects, it is important to consult your healthcare provider. Furthermore, this medication may interact with other drugs, hence it is crucial to inform your healthcare provider about all the medications you are currently taking.
If you have any queries about Buprenorphine 0.5% Nasal Spray or its mechanism of action, do not hesitate to reach out to your healthcare provider. They are equipped with the necessary knowledge and expertise to guide you through your treatment journey.
Buprenorphine 0.5% Nasal Spray is a liquid formulation delivered in a spray form, specifically designed for administration into the nasal cavity. It provides targeted local or systemic effects through the nostrils.
The spray works by delivering the medication directly into the nasal cavity, where it is quickly absorbed into the bloodstream. This allows for a rapid onset of effects, which can be either local or systemic depending on the specific medication used.
The spray should be administered as directed by your healthcare provider. Typically, it is sprayed into each nostril, with the exact number of sprays and frequency of use depending on your specific medical condition and response to treatment.
Side effects can vary depending on the individual and the specific medication used. Common side effects may include nasal irritation, dryness, or discomfort. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
If you have a cold or nasal congestion, it may affect the absorption of the medication. It's recommended to discuss this with your healthcare provider before using the spray.
It's important to tell your healthcare provider about all the medications you're currently taking, as some may interact with Buprenorphine 0.5% Nasal Spray. Your healthcare provider will be able to advise you on whether it's safe to use the spray with your other medications.
If you miss a dose, take it as soon as you remember. If it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses to make up for a missed one.
Buprenorphine is a type of opioid medication, and long-term use can lead to physical dependence. However, when used as directed by a healthcare provider, the risk of dependence is low. If you have concerns about dependence or addiction, discuss these with your healthcare provider.
If you're pregnant or breastfeeding, you should discuss the potential risks and benefits of using Buprenorphine 0.5% Nasal Spray with your healthcare provider. The medication can pass into breast milk and may have effects on a nursing infant.
If you suspect an overdose, seek emergency medical attention immediately. Symptoms of an overdose may include severe drowsiness, slow breathing, or loss of consciousness.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale intranasally
